Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Long

Adult Reconstructive Orthopaedic Surgery New York, NY Medical Doctor

NPI 1588636245 CMS profile 162914

535 E 70Th St, New York, NY 10021

Open in the dashboard

General payments

$1,545,589

403 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$266,950 paid to institutions, not to them · program years 2019–2023

Through program year 2025, William Long of New York, NY is reported in the CMS Open Payments database as having received $1,545,589 across 403 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $266,950 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $853,628 116
2024 General $54,064 48
2023 General $63,864 35
2022 General $288,543 38
2021 General $95,431 62
2020 General $87,829 50
2019 General $102,231 54

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Long
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to William Long were reported at $853,628. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year William Long Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $102,231 $1,416 $292–$9,336 $163
2020 $87,829 $647 $141–$6,474 $114
2021 $95,431 $1,073 $211–$6,497 $132
2022 $288,543 $1,217 $236–$6,299 $149
2023 $63,864 $1,082 $246–$6,818 $160
2024 $54,064 $1,575 $323–$8,944 $164
2025 $853,628 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $860,849 149 payments
  2. DePuy Synthes Products, Inc. $262,858 28 payments
  3. Ortho Development Corporation $210,485 71 payments
  4. Medical Device Business Services, Inc. $71,085 56 payments
  5. ConvaTec Inc. $60,112 22 payments
  6. Think Surgical, Inc. $42,218 6 payments
  7. MicroPort Orthopedics Inc $20,465 16 payments
  8. Total Joint Orthopedics, Inc. $10,240 16 payments
  9. Globus Medical, Inc. $2,458 7 payments
  10. Synthes GmbH $2,143 3 payments
  11. Other $2,677 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,018,532 85 payments
  2. Royalty or License $434,025 77 payments
  3. Education $60,882 16 payments
  4. Travel and Lodging $20,993 92 payments
  5. Food and Beverage $9,658 132 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $1,500 1 payment
Products named General payments · program years 2019–2025
  1. Balance Knee Revision System $123,843 36 payments
  2. ATTUNE Ortho-Knee $68,879 40 payments
  3. Persona $63,105 29 payments
  4. BKS Revision $55,179 24 payments
  5. G7 $43,859 14 payments
  6. Avenir $43,554 10 payments
  7. Tsolution One Surgical System $42,218 6 payments
  8. ATTUNE Ortho-Knee $42,126 35 payments
  9. Balanced Knee Revision System $31,463 11 payments
  10. AQUACEL Ag Surgical $20,144 7 payments
  11. Other $89,722 127 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 29 billing codes

Paid by Medicare

$161,458

Of which drugs: $7,467

Medicare patients

304

Average age 74

Services billed

2,132

192 women, 112 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Ischemic heart disease 34%
Diabetes 25%
Osteoporosis 20%
Cancer 17%
Depression 14%
Atrial fibrillation 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 18 1,600 $168

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

403 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record